Afshar-Oromieh Ali, Wolf Maya B, Kratochwil Clemens, Giesel Frederik L, Combs Stephanie E, Dimitrakopoulou-Strauss Antonia, Gnirs Regula, Roethke Matthias C, Schlemmer Heinz P, Haberkorn Uwe
Department of Nuclear Medicine, University Hospital of Heidelberg, Heidelberg, Germany (A.A.-O., C.K., F.L.G., U.H.); Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany (A.A.-O., M.B.W., R.G., M.C.R., H.P.S.); Clinical Cooperation Unit of Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany (A.A.-O., A.D.-S.); Department of Radiation Oncology and Therapy, University Hospital of Heidelberg, Heidelberg, Germany (S.E.C.).
Neuro Oncol. 2015 Feb;17(2):312-9. doi: 10.1093/neuonc/nou131. Epub 2014 Jul 9.
(68)Ga-DOTATOC-PET/CT is a well-established method for detecting and targeting the volume definition of meningiomas prior to radiotherapy. Moreover, there is evidence that this method is able to detect meningiomas with higher sensitivity than the goldstandard MRI. Since the hybrid PET/MRI scanner became available in the past few years, the next stage of development could consequently evolve by evaluating the feasibility of a hybrid PET/MRI scanner using (68)Ga-DOTATOC for detecting meningiomas.
Fifteen patients received (68)Ga-DOTATOC-PET/CT (0.5 h post injection [p.i.]) followed by PET/MRI 2 hours p.i. Both investigations were analyzed separately and then compared with respect to image quality, detection of intracranial meningiomas, and radiotracer uptake values (RUVs). In addition, ratios between radiotracer uptake in meningiomas and pituitary glands were compared between both PET/CT and PET/MRI.
Overall, 33 intracranial meningiomas were detected. All were visible with high contrast in both PET/CT and PET/MRI. (68)Ga-DOTATOC-PET/MRI provided flawless image quality without artefacts. Calculated RUV in meningiomas, as well as the ratios of RUVs in meningiomas to those of pituitary glands, were higher in PET/CT. As a result, meningiomas can be distinguished from pituitary glands better in early images.
(68)Ga-DOTATOC-PET/MRI provided flawless image quality and presented an ideal combination of high sensitivity/specificity (PET) and the best possible morphological visualization of meningiomas (MRI). In addition, excellent detection of meningiomas is already possible at 0.5 hours p.i. Later images do not improve the distinction between pituitary gland and adjacent meningiomas. However, RUVs need to be carefully compared between both imaging modalities.
(68)Ga - DOTATOC - PET/CT是一种在放射治疗前检测和确定脑膜瘤体积的成熟方法。此外,有证据表明该方法检测脑膜瘤的灵敏度高于金标准MRI。由于过去几年混合PET/MRI扫描仪已可用,因此下一阶段的发展可以通过评估使用(68)Ga - DOTATOC的混合PET/MRI扫描仪检测脑膜瘤的可行性来推进。
15名患者接受了(68)Ga - DOTATOC - PET/CT(注射后0.5小时),随后在注射后2小时进行PET/MRI。两项检查分别进行分析,然后在图像质量、颅内脑膜瘤的检测以及放射性示踪剂摄取值(RUVs)方面进行比较。此外,还比较了PET/CT和PET/MRI两者之间脑膜瘤与垂体的放射性示踪剂摄取比值。
总体而言,共检测到33个颅内脑膜瘤。在PET/CT和PET/MRI中均能以高对比度清晰显示。(68)Ga - DOTATOC - PET/MRI提供了无伪影的完美图像质量。脑膜瘤的计算RUV以及脑膜瘤与垂体的RUV比值在PET/CT中更高。因此,在早期图像中脑膜瘤与垂体的区分更好。
(68)Ga - DOTATOC - PET/MRI提供了完美的图像质量,呈现出高灵敏度/特异性(PET)与脑膜瘤最佳形态可视化(MRI)的理想组合。此外,在注射后0.5小时就已经能够很好地检测到脑膜瘤。后期图像并不能改善垂体与相邻脑膜瘤之间的区分。然而,需要仔细比较两种成像方式之间的RUVs。